These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B. Oncogene; 1995 Aug 03; 11(3):587-96. PubMed ID: 7630643 [Abstract] [Full Text] [Related]
3. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max. Västrik I, Mäkelä TP, Koskinen PJ, Alitalo K. Oncogene; 1995 Aug 03; 11(3):553-60. PubMed ID: 7630640 [Abstract] [Full Text] [Related]
5. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex. Peña A, Wu S, Hickok NJ, Soprano DR, Soprano KJ. J Cell Physiol; 1995 Feb 03; 162(2):234-45. PubMed ID: 7822433 [Abstract] [Full Text] [Related]
6. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H. Nature; 1992 Oct 01; 359(6394):423-6. PubMed ID: 1406955 [Abstract] [Full Text] [Related]
7. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Wu S, Peña A, Korcz A, Soprano DR, Soprano KJ. Oncogene; 1996 Feb 01; 12(3):621-9. PubMed ID: 8637719 [Abstract] [Full Text] [Related]
8. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively. Vervoorts J, Lüscher B. Biol Chem; 1999 Sep 01; 380(9):1121-6. PubMed ID: 10543451 [Abstract] [Full Text] [Related]
12. DNA binding by N- and L-Myc proteins. Ma A, Moroy T, Collum R, Weintraub H, Alt FW, Blackwell TK. Oncogene; 1993 Apr 01; 8(4):1093-8. PubMed ID: 8455937 [Abstract] [Full Text] [Related]
13. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer. Västrik I, Mäkelä TP, Koskinen PJ, Saksela K, Alitalo K. Princess Takamatsu Symp; 1991 Apr 01; 22():307-18. PubMed ID: 1668890 [Abstract] [Full Text] [Related]
14. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Larsson LG, Bahram F, Burkhardt H, Lüscher B. Oncogene; 1997 Aug 07; 15(6):737-48. PubMed ID: 9264414 [Abstract] [Full Text] [Related]
15. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT, León J. Oncogene; 1995 Apr 20; 10(8):1659-65. PubMed ID: 7731722 [Abstract] [Full Text] [Related]
16. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper. Lavigne P, Crump MP, Gagné SM, Hodges RS, Kay CM, Sykes BD. J Mol Biol; 1998 Aug 07; 281(1):165-81. PubMed ID: 9680483 [Abstract] [Full Text] [Related]
17. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. Wang Z, Ge L, Wang M, Carr BI. J Cell Physiol; 2006 Jul 07; 208(1):133-40. PubMed ID: 16596619 [Abstract] [Full Text] [Related]
18. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc. Gupta K, Anand G, Yin X, Grove L, Prochownik EV. Oncogene; 1998 Mar 05; 16(9):1149-59. PubMed ID: 9528857 [Abstract] [Full Text] [Related]
19. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism. Buckle RS, Méchali M. Oncogene; 1995 Mar 16; 10(6):1249-55. PubMed ID: 7700652 [Abstract] [Full Text] [Related]
20. Protein complexes bearing myc-like antigenicity recognize two distinct DNA sequences. Negishi Y, Iguchi-Ariga SM, Ariga H. Oncogene; 1992 Mar 16; 7(3):543-8. PubMed ID: 1549367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]